Senior Director, Market Access Strategy, International

Academic Key; San Francisco (CA); On-site; USD 180,000 - 240,000; Full time

Job summary

BridgeBio Pharma, Inc. is seeking a global Market Access professional to drive pricing and reimbursement strategies across international markets. You will secure timely patient access by shaping value narratives and leading cross-regional initiatives with HEOR, regulatory, and commercial teams.

The role requires deep expertise in HTA processes and payer interactions, with a focus on pre-launch and launch activities for rare disease programs in a fast-paced biotech setting.

Qualifications

• Experience in market access processes across international markets.
• Strong collaboration with cross-functional teams.

Responsibilities

• Represent the payer perspective within cross-functional commercialization teams to optimize pricing and market access.
• Lead early payer engagement with key HTA bodies (e.g. NICE UK, G-BA Germany) to inform evidence and reimbursement strategies.
• Collaborate with HEOR, Marketing, and Clinical Development to align value propositions and access outcomes.

Job description

Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask \"why not?\" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. About BridgeBio Pharma, Inc. BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients living with genetic diseases and genetically defined cancers. Since our founding in 2015, we have built a diverse portfolio of more than 20 drug development programs, ranging from early discovery to late-stage clinical trials, across multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, and renal disease. We have already achieved regulatory approval for three therapies and continue to advance promising science from academia into meaningful treatments for patients worldwide. Who We Are BridgeBio is a global biotechnology company with our Global Headquarters located in San Francisco, USA, and our International HQ located in Zug, Switzerland. Since establishing our European presence in 2021, we’ve been building empowered, high-performing teams across countries — with experienced colleagues who move quickly, take ownership, and are fueling the company’s international growth. At BridgeBio, you’ll find an energetic and collaborative culture where pragmatism meets bold decision-making. We embrace uncertainty with confidence, guided by our commitment to making a meaningful impact for patients. Our people are trusted and empowered, united by urgency, purpose, and the drive to advance science for patients around the world. To learn more about our story and company culture, visit us at https://bridgebio.com What You’ll Do You will report to the VP, Head of Market Access, International and work closely with international Market Access, regional brand team, and heads or markets access in BridgeBio clusters as well as with field-based colleagues across multiple geographies, to drive strategic initiatives that support BridgeBio’s mission of delivering transformative medicines to patients globally. Your primary purpose will be to secure timely, sustainable patient access to the company’s products by shaping the value narrative, and leading pricing and reimbursement strategies and execution across multiple international markets. This includes oversight of related dossiers, negotiations, and cost coverage approaches. In this role you ensure alignment of Market Access ambitions with clinical value and global pricing interdependencies. You will also be a core member of the International Market Access team, contributing to global decision-making and ensuring alignment across regions while representing diverse market perspectives. This role requires strong collaboration with cross-functional colleagues and external stakeholders across multiple countries to ensure high-quality execution and impact. The ideal candidate combines deep expertise in Market Access processes across several international markets and experience introducing innovative therapies in a global biotech environment. You are eager to make a meaningful contribution in pre-launch and launch phases, particularly within rare diseases and orphan conditions, and bring strong communication skills, adaptability, and the ability to thrive in a fast-paced, hands-on environment. Responsibilities Represent the payer perspective within cross-functional, cross-regional commercialization teams thereby optimizing pricing and market access of the asset. Closely collaborate with HEOR and clusters' leadership teams, Marketing and Clinical Development counterparts to ensure value and access optimization for the asset. Lead early payer engagement with key HTA/payer bodies (e.g. NICE UK, G-BA Germany) to inform evidence generation strategy, value proposition and reimbursement dossiers development. Interact with internal and external experts in pricing, health economics, patient advocacy, health technology assessment authorities, government policy makers and payers as